Bookmark

Add to MyYahoo RSS

Advanced Transit Dynamics News

News on Advanced Transit Dynamics (Ticker: JNJ) continually updated from thousands of sources around the net.

3 hrs ago | Seeking Alpha

Earnings Preview: Johnson & Johnson Q2 2014

Johnson & Johnson is slated to report 2Q 2014 earnings before the opening bell on Tuesday, July 15th.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, VisionCare Ophthalmic Technologies, Startups

4 hrs ago | The Washington Post

Spinversions Make Giants Candidates to Escape U.S. Tax: Real M&A

American conglomerates that want a piece of the tax-inversion deal bonanza may start turning to a new tactic.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

8 hrs ago | Philadelphia Gay News

N.J.-based corp. marks third year of LGBT initiative

Five years ago, Johnson & Johnson started hosting Gay 101 "lunch and learns" to find out more about the LGBT community as a consumer group.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Wed Jul 09, 2014

Seeking Alpha

Has Johnson & Johnson Finally Met Its Match?

In the latest instalment of our Head-To-Head series, we pitch two companies from the health care sector, Johnson & Johnson and Covidien, against one another.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

GigaOM

White House pulls plug on controversial Patent Office nominee after tech sector backlash

The Obama Administration has backed away from an unpopular plan to name a Johnson & Johnson executive and patent reform opponent as head of the US Patent Office.

Comment?

Related Topix: Patent / Trademark Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Tue Jul 08, 2014

Montreal Gazette

Energizer Holdings to shut Montreal factory; 430 jobs gone

Just nine months after buying the east-end Johnson & Johnson factory, Energizer Holdings announced Tuesday it will shut down the facility beginning next summer.

Comment?

Related Topix: Energizer HLDGS, Electronics, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

BioSpace

Oxford BioTherapeutics Appoints As Head Of Clinical Development

Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates for the treatment of cancer, announced today the appointment of Eugen Leo, MD, PhD, MBA, as Head of Clinical Development.

Comment?

Related Topix: Medicine, Cancer, Health, LOC-AID Technologies, Oncology, Colorado State University, Real Estate, ADC

BioSpace

Why This Johnson & Johnson Exec Shouldn't Be the Next U.S. Patent Office Director

Philip Johnson is Chief Intellectual Property Counsel of Johnson & Johnson, one of the largest pharmaceutical companies in the world.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Patent / Trademark Law, Law, VisionCare Ophthalmic Technologies, Startups

Sun Jul 06, 2014

Hecklerspray

Chris Martin Is Giving Gwyneth A Meaty Middle Finger

Chris Martin had to give up a lot during his marriage to Gwyneth Paltrow . His dignity, warmth and affection, the ability to use normal products like Johnson&Johnson soap and tap water.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Fri Jul 04, 2014

Seeking Alpha

Johnson & Johnson: Valuation Not Attractive Despite Impressive Strategic Alliance

Despite this Johnson & Johnson is expected to grow at a CAGR of ~10% for the next five years, its valuation isn't attractive enough.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Thu Jul 03, 2014

Medford Mail Tribune

Hip-replacement lawsuits continue to increase locally

ACentral Point man who had heavy metals enter his bloodstream from his hip-replacement device is joining nearly 100 others locally who have filed lawsuits against the device manufacturer.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Wed Jul 02, 2014

Business Journal

Artificial hip maker must pony up $4M to Oregon for 'alarming failure rate of failure'

The Oregon Department of Justice reached a $4 million settlement with a subsidiary of Johnson & Johnson over allegations of deceptive marketing practices surrounding artificial hip devices.

Comment?

Related Topix: Oregon Government, Oregon, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, DePuy Orthopaedics, Johnson and Johnson Merck Consumer Pharmaceuticals, Medical Equipment, Healthcare Industry

Business Journal

Report: DePuy Synthes eliminating 400 positions

Johnson & Johnson is eliminating about 400 jobs at its DePuy Synthes medical device subsidiary, according to a Wall Street Journal report .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Seeking Alpha

Outlook For July 2014

Summer is finally here! The stock market continues to hover around the all-time highs relentlessly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Mon Jun 30, 2014

Adweek

Fisher-Price Targets Millennial Moms for the Royal Baby's Birthday

The idea of brands becoming publishers has been around for a couple years , as businesses have en masse created social media pages and content blogs to promote their wares.

Comment?

Related Topix: Media, BabyCenter, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Sun Jun 29, 2014

Mydigitalfc.com

FIPB to take up 31 foreign investment proposals on July 4

Finance Ministry will take a call on 31 proposals of foreign direct investment, including that of Johnson & Johnson and Monsanto Holdings, next week.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Thu Jun 26, 2014

Freshnews

Corporate Action Network and Ohio Women Request Attorney General...

Citing their personal health problems and costs incurred, Ohio women who have been seriously injured by pelvic mesh implants requested that Ohio Attorney General Mike DeWine investigate the pelvic mesh industry for its dangerous implants.

Comment?

Related Topix: Healthcare Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Journal Gazette

DePuy cuts jobs in Warsaw

DePuy Synthes Cos. has eliminated an undisclosed number of jobs, affecting a portion of the company's Warsaw workforce, an official confirmed Wednesday.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, DePuy Orthopaedics, Medical Equipment

Wed Jun 25, 2014

GuruFocus.com

Buy These Dividend Stocks on the Pullback

Over the last few years, investors have piled into high-quality dividend stocks in search of yield.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

The Motley Fool

A Smart Move for Endo International?

Over the past two months management has given investors another two examples of its ability to generate value - settling a large part of its vaginal mesh litigation and announcing another accretive M&A transaction.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••